ARTA
TBRA

A.R.T. Advisors’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

A.R.T. Advisors’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-12,860
Closed -$124K – 1902
2015
Q3 		$124K Sell
12,860
-956
-7% -$13.4K ﹤0.01% 1233
2015
Q2 		$238K Buy
+13,816
New +$202K 0.01% 1256

Other funds holding TBRA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

A.R.T. Advisors's TBRA Position: Q4 2015 in Review

A.R.T. Advisors sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2015, closing a stake of 12,860 shares — an estimated $124K sold.

A.R.T. Advisors first reported a position in TBRA in Q2 2015 and held it in 2 quarters. The position peaked at $238K in Q2 2015. 48 funds tracked by Wall St. Rank hold TBRA as of Q4 2015.

  • A.R.T. Advisors reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • A.R.T. Advisors sold 12,860 Tobira Therapeutics, Inc. Common Stock shares in Q4 2015, an estimated $124K.
  • A.R.T. Advisors first reported a position in Tobira Therapeutics, Inc. Common Stock in Q2 2015 and held it in 2 quarters.
  • A.R.T. Advisors's Tobira Therapeutics, Inc. Common Stock position peaked at $238K in Q2 2015.
  • 48 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2015.

Based on A.R.T. Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.